Posts by: Marta Figueiredo

Marta Figueiredo

December 7, 2018December 7, 2018

Newer Anti-epileptic Therapies May Be Safer, More Effective in Reducing Seizures in Angelman’s Patients

News

Newer anti-epileptic medications — such as Keppra (levetiracetam), Lamitcal (lamotrigine), and clobazam — as well as low glycemic index treatment may be more effective in reducing epileptic seizures and ... Read more

July 6, 2018July 6, 2018

Mutations in UBE3A Gene Impair Normal Development of Brain Circuits, Review Suggests

News

UBE3A, the protein underlying Angelman syndrome, is crucial for the maturation and adaptability of the visual circuits in the brain, according to a recent review study. The study, “Common Defects ... Read more

July 2, 2018July 2, 2018

Chromosomal Diagnostic Test Allows for Early Diagnosis, Better Treatment Planning in Angelman Patients

News

A molecular technique, known as chromosomal microarray analysis, enables early diagnosis of several genetic neurodevelopmental disorders — including Angelman syndrome — and improved treatment management, according to a Chinese ... Read more

March 23, 2018March 23, 2018

Newly Identified Molecular Targets Have Potential Implications for Angelman Syndrome

News

New targets of the UBE3A enzyme responsible for Angelman syndrome have been identified, increasing scientific knowledge behind the molecular processes leading to this disease. The study, “Quantitative proteomics reveals ... Read more

Pin It on Pinterest